ADZYNMA 500 IU, powder and solvent for solution for injection bottle, 5 ml
Active ingredients: ADAMTS13R, ADAMTS13R Q23 NATIF, VARIANT ADAMTS13R R23
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for injectionbottle, 5 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ADZYNMA 500 UI, poudre et solvant pour solution injectable
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon en verre de 500 UI de poudre + 1 flacon en verre de 5 mL de solvant + 1 dispositif de reconstitution + 1 seringue + 1 set de perfusion + 2 tampons alcoolisés
- Marketing authorisation holder
- TAKEDA MANUFACTURING AUSTRIA (AUTRICHE)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Nov 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
66193589CIP73029779CIP133400930297797Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ADAMTS13Rpoudre | 500 UI · un flacon | SA |
| ADAMTS13R Q23 NATIFpoudre | — | FT |
| VARIANT ADAMTS13R R23poudre | — | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.